Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
We shown how to stop immune cells from attacking the nervous system cells.
LightField Studios/ Shutterstock
A promising new approach to treating MS tricks defective immune cells into thinking they are attacking the body, when they are in fact being attacked themselves.
Terry Wahls before and after she changed her diet.
Biological research can inspire technological innovation. Also, software that models computer networks can inform health care for patients with neurological disorders.
People exposed to low levels of sunlight are more likely to have MS than those who live in warm climates.
chuttersnap
Trevor Kilpatrick, Florey Institute of Neuroscience and Mental Health
Young women are disproportionately affected by multiple sclerosis, a disease where the body attacks the brain, scrambling communication to the rest of the body. Here’s what we know about the causes.
All multiple sclerosis sufferers have stem cells with the potential to heal them, but scientists are only just figuring out how to kick them into action.
Women’s immune systems mount a significantly stronger response against invaders.
wavebreakmedia/Shutterstock
Gabrielle Belz, WEHI (Walter and Eliza Hall Institute of Medical Research) and Cyril Seillet, WEHI (Walter and Eliza Hall Institute of Medical Research)
Women have evolved to have stronger immunity than men. But this comes with downsides -
women are more likely to have autoimmune diseases due to their “reactive” immune systems.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer.
from shutterstock.com
Fingolimod is a drug used to treat multiple sclerosis (MS), an autoimmune disease. It is an immunomodulator, which means it works by suppressing the immune system.
The risks of UV radiation exposure are well-known, but some scientists are exploring lesser-known benefits of UV light.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached.
EPA/Erik S. Lesser
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
Professor- Departments of Medical Microbiology & Immunology and Dermatology | Member- Foods For Health Institute | Member- Comprehensive Cancer Center | Director- Autoimmunity | Director- Immune Monitoring, University of California, Davis